Articles

Tech giants desperate to power AI data centers are turning to nuclear disaster sites — despite the risks

The tech industry’s need for more power for data centers running artificial intelligence is now so desperate that companies are turning to nuclear disaster sites, despite the potential risks.

The Fed decision’s lone dissenter worries the bigger rate cut sends a ‘premature victory’ message to markets

Michelle Bowman was the first Federal Reserve governor to dissent from an interest-rate decision since 2005.

The fan who caught Shohei Ohtani’s 50th home-run ball could make $500,000

Aaron Judge’s 62nd home-run ball in 2022 sold for $1.5 million at auction

The Fed rate cut scared me. Where should I invest my $127,000 in savings now?

This reader wonders whether CD rates, high-yield savings accounts and bond ladders are still smart moves, even if interest rates keep dropping.

Uranium ETFs rally amid plans to revive nuclear reactor in Microsoft agreement

Constellation Energy said Friday it plans to restart a nuclear reactor at Three Mile Island.

Here’s how you should invest if you reject the Fed’s ‘fairy tales’

Also: What to expect for loan interest rates, how Social Security survivor and spousal benefits work, and advice from the Moneyist.

Jamie Dimon: Only 5% of everyday Americans probably know about the Fed’s historic interest-rate cut

JPMorgan Chase CEO Jamie Dimon suggests the half-point interest-rate cut is “a minor thing” that Wall Street — not Main Street — is obsessing over.

Shohei Ohtani, the first to ever achieve 50/50, is the 352nd highest-paid player in MLB this season

That’s in part because most of his $700 million contract is deferred. Still, his stats this season are worth over $50 million to his team.

Micron’s stock sentiment is weak. Here’s what could flip the script.

Micron shares have shed most of their 2024 gains, but memory pricing could improve in the coming months, Citi says.

With meme stocks in a lull, here’s where retail investors may turn their attention next

The dynamics that fueled the meme-stock frenzy have not gone away, according to a new study.

FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.

Social Security’s COLA provides invaluable protection

Recent inflation spike — and moderation — underscores its importance
1 922 923 924 925 926 2,477